Tower Research Capital (TRC)’s Climb Bio CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40K Buy
5,836
+2,479
+74% +$14.3K ﹤0.01% 2947
2025
Q4
$13.4K Sell
3,357
-9,887
-75% -$23.7K ﹤0.01% 3406
2025
Q3
$26.6K Sell
13,244
-858
-6% -$1.59K ﹤0.01% 3051
2025
Q2
$17.5K Buy
14,102
+5,972
+73% +$7.43K ﹤0.01% 3751
2025
Q1
$9.92K Buy
8,130
+2,536
+45% +$4.11K ﹤0.01% 3705
2024
Q4
$10.1K Buy
5,594
+3,037
+119% +$11K ﹤0.01% 3848
2024
Q3
$13K Sell
2,557
-463
-15% -$3.27K ﹤0.01% 3547
2024
Q2
$21.5K Sell
3,020
-586
-16% -$3.9K ﹤0.01% 3718
2024
Q1
$9.88K Buy
3,606
+151
+4% +$415 ﹤0.01% 3779
2023
Q4
$9.33K Sell
3,455
-441
-11% -$1.15K ﹤0.01% 4407
2023
Q3
$10.2K Sell
3,896
-858
-18% -$2.34K ﹤0.01% 4134
2023
Q2
$13.3K Buy
4,754
+1,492
+46% +$4.53K ﹤0.01% 3779
2023
Q1
$9K Buy
3,262
+2,620
+408% +$9K ﹤0.01% 4558
2022
Q4
$2K Sell
642
-339
-35% -$1.01K ﹤0.01% 5444
2022
Q3
$3K Buy
981
+541
+123% +$1.73K ﹤0.01% 5445
2022
Q2
$1K Sell
440
-1,991
-82% -$9.42K ﹤0.01% 5880
2022
Q1
$20K Buy
2,431
+1,430
+143% +$13.3K ﹤0.01% 3554
2021
Q4
$10K Buy
1,001
+510
+104% +$7.6K ﹤0.01% 4625
2021
Q3
$9K Buy
+491
New +$10.1K ﹤0.01% 4479

Other funds holding CLYM